On the other hand, Sox2 down-regulation in GBM CSCs causes cell growth arrest and loss of in vivo tumorigenicity [77], further confirming the relevance of the alterations induced by PrPC-KO we highlight in this study. The gene discussed is SOX2; the disease is glioblastoma.